EGFR and cancer: Sentani and colleagues reported that mixed type GC showed a characteristically expression of cancer stem cell-related molecules (CD44, CD133, and ALDH1), receptor tyrosine kinase molecules (EGFR, c-MET, and HER2), and chromosomal instability compared to pure type GC [27].